| Literature DB >> 32154156 |
Yosie Andriani1, Gul-E-Saba Chaudhry1, Efriyana Oksal1, Inten Pangestika1, Nadia Madiha Ramli1, Habsah Mohamad1, Rina Elvia2, Hermansyah Amir2, Effendy Awm3,4, Yeong Yik Sung1, Tengku Sifzizul Tengku Muhammad1,5.
Abstract
Atherosclerosis is a leading cause of death worldwide. The adverse side effects of currently available drugs urge to find more effective and safe remedial agents. Alternative candidates from natural resources are of great consequence in the emerging of new drugs. Pandanus tectorius (Pandanaceae) was traditionally used in Ayurvedic medicine to cure certain diseases. Thus, the current study conducted to elucidate the potency of P. tectorius fruit as antiatherosclerosis and antihypercholesterolemia agents through the regulation of high density lipoprotein (HDL) receptor (scavenger receptor [SR]-B1) gene expression and 3-hydroxy-3-methylglutaryl coenzyme A reductase reductase (HMGCR) in vitro, respectively. The P. tectorius fruit was noncytotoxic against the HepG2 cell line confirmed by 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyl tetrazolium bromide assay. The P. tectorius fruit successfully upregulates the SR-B1 gene expression and downregulate the HMGCR. Moreover, an in vivo study showed that P. tectorius has good activity on the upregulation of HDL and subsequently downregulation of total cholesterol level. Moreover, P. tectorius fruit did not show any increase in toxicity biomarkers serum glutamic oxaloacetic transaminase and serum glutamate pyruvate transaminase in vivo. These results found that P. tectorius fruits have potency as the preventive agent for hypercholesterolemia and atherosclerosis via SR-B1 and HMGCR mechanisms of action. Copyright:Entities:
Keywords: 3-hydroxy-3-methylglutaryl coenzyme A reductase; Pandanus tectorius; antiatherosclerosis; antihypercholesterolemia; scavenger receptor-B1
Year: 2020 PMID: 32154156 PMCID: PMC7034180 DOI: 10.4103/japtr.JAPTR_164_19
Source DB: PubMed Journal: J Adv Pharm Technol Res ISSN: 0976-2094
Figure 1Cytotoxicity property PHK, PEK and PMK of Pandanus tectorius fruit against HepG2 cell lines. PHK (Pandanus Hexane Extract), PEK (Pandanus Ethyl acetate Extract) and PMK (Pandanus Mathanol Extract)
Figure 2The activity value of scavenger receptor-B1 promoter that given PHK, PEK, PMK and positive control (rosiglitazone)
Figure 3(a-c) The effect of PHK on 3-hydroxy-3-methylglutaryl coenzyme A reductase reductase activity at concentration of 400, 200, and 100 μg/mL compare to the inhibitor (Pravastatin)
Figure 4Rats body weight during 42 days of treatment that taken each week
Figure 5The reduction of total cholesterol levels during treatment on groups of standard food (A); control cholesterol food (B); PEK 500 g/kg BW (C); and PMK 500 g/kg BW (D)
Figure 6The HDL cholesterol level during 42-day treatment
The serum glutamic oxaloacetic transaminase activities of rat plasma during treatment on each group
| Group | Activity of SGOT (U/I) for every 7 days during treatment | ||||||
|---|---|---|---|---|---|---|---|
| Day 0 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
| A | 134.23±1.04 | 134.51±1.28 | 134.25±1.41 | 134.19±0.95 | 134.25±0.86 | 134.19±0.888 | 134.02±1.15 |
| B | 134.32±1.14 | 137.14±0.93* | 137.35±1.19* | 138.53±1.41* | 137.93±1.22* | 137.78±1.22* | 137.91±1.17* |
| C | 134.65±0.68 | 133.59±0.96 | 132.30±1.55 | 132.32±1.13 | 132.42±1.99 | 132.54±2.07 | 132.70±1.07 |
| D | 134.63±0.58 | 134.14±0.75 | 134.40±0.84 | 134.93±0.62 | 135.13±0.77 | 135.38±0.41 | 135.29±0.87 |
Group A as control of standard food, Group B as control of cholesterol food, Group C as PEK (Pandanus Ethyl acetate Extract), and Group D as PMK (Pandanus Methanol Extract). *P<0.05 significantly different in comparison among normal, cholesterol, and treatment group; each value is presented as mean±SD (n=10). SGOT: Serum glutamic oxaloacetic transaminase, SD: Standard deviation
The serum glutamate pyruvate transaminase activities of rat plasma during treatment on each group
| Group | Activity of SGPT (U/I) for every 7 days during treatment | ||||||
|---|---|---|---|---|---|---|---|
| Day 0 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
| A | 64.46±1.20 | 63.95±1.61 | 64.73±1.23 | 64.96±1.18 | 64.85±1.12 | 65.15±0.94 | 64.34±0.57 |
| B | 64.66±0.68 | 67.32±1.66* | 66.95±2.98* | 71.83±0.41* | 70.99±4.13* | 71.17±1.78* | 71.39±2.47* |
| C | 64.87±0.86 | 65.98±0.76 | 66.46±0.94 | 64.95±1.31 | 65.04±1.28 | 64.87±0.89 | 64.87±0.96 |
| D | 65.21±0.69 | 65.70±0.97 | 65.74±0.94 | 65.83±0.95 | 65.52±0.90 | 65.10±0.83 | 65.69±1.19 |
Group A as control of standard food, Group B as control of cholesterol food, Group C as PEK, and Group D as PMK. *P<0.05 significantly different in comparisn among normal, cholesterol, and treatment group; each value is presented as mean±SD (n =10). SGPT: Serum glutamic pyruvate transaminase, SD: Standard deviation